P/E ratio for Antares Pharma (ATRS)
P/E ratio at the end of 2020: 11.9
According to Antares Pharma's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 16.4412. At the end of 2020 the company had a P/E ratio of 11.9.
P/E ratio history for Antares Pharma from 2001 to 2020
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2020 | 11.9 | -102.55% |
| 2019 | -465 | 554.93% |
| 2018 | -71.0 | 292.46% |
| 2017 | -18.1 | 24.23% |
| 2016 | -14.6 | 64.42% |
| 2015 | -8.86 | -6.95% |
| 2014 | -9.52 | -64.58% |
| 2013 | -26.9 | -30.91% |
| 2012 | -38.9 | -11.59% |
| 2011 | -44.0 | 80.12% |
| 2010 | -24.4 | 213.76% |
| 2009 | -7.79 | 335.08% |
| 2008 | -1.79 | -73.9% |
| 2007 | -6.86 | -8.57% |
| 2006 | -7.50 | 1.61% |
| 2005 | -7.38 | 24.82% |
| 2004 | -5.91 | 1093.56% |
| 2003 | -0.4954 | 63.35% |
| 2002 | -0.3033 | -85.57% |
| 2001 | -2.10 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 10.6 | -35.61% | 🇺🇸 USA |
 Pfizer PFE | 14.1 | -14.13% | 🇺🇸 USA |
 Eli Lilly LLY | 135 | 719.29% | 🇺🇸 USA |
 Becton Dickinson BDX | 42.1 | 156.31% | 🇺🇸 USA |
 ANI Pharmaceuticals ANIP | -140 | -949.19% | 🇺🇸 USA |
 Retractable Technologies RVP | -15.3 | -192.97% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | -6.44 | -139.17% | 🇮🇱 Israel |
 West Pharmaceutical WST | 50.0 | 203.99% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.